Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 27 - Drugs for disorders of the senses
Patents for A61P 27 - Drugs for disorders of the senses (53,017)
11/2012
11/21/2012CN102784290A Traditional Chinese medicine composition for treating tinnitus
11/21/2012CN102784281A Chrysanthemum rhizoma anemarrhenae oral liquid
11/21/2012CN102784245A Erding granule and preparation method thereof
11/21/2012CN102784238A Application of drug composition in drug preparation for preventing or treating neovascular diseases
11/21/2012CN102784184A Externally applied agent for treatment of functional ear disease
11/21/2012CN102784161A Specific ear drops for treating acute/chronic tympanitis
11/21/2012CN102784141A Solid preparation of ambroxol hydrochloride and amoxicillin, and prescription and preparation method thereof
11/21/2012CN102389412B Eye drops for treating cataract
11/21/2012CN102327210B Vinpocetine suspension injection
11/21/2012CN102258460B Baicalein liposome gel and preparation method thereof
11/21/2012CN102153672B Method for extracting chondroitin sulfate
11/21/2012CN102008474B Application of nitidine chloride to preparation of medicament for treating autoimmune disease and graft rejection disease
11/21/2012CN102008468B Application of Incarvillea delavay alkali in preparing drug for resisting autoimmune diseases and graft rejection diseases
11/21/2012CN101987157B Medicine for treating nearsightedness and preparation method thereof
11/21/2012CN101959524B 抗过敏剂 Antiallergic agent
11/21/2012CN101553206B Water insoluble polymer matrix for drug delivery
11/20/2012US8314104 Method of treating diabetes
11/20/2012CA2558896C Methods for the treatment of tinnitus induced by cochlear excitotoxicity
11/20/2012CA2540328C Compositions and methods of using lamellar bodies for therapeutic purposes
11/20/2012CA2492989C Ophthalmic ointment composition comprising a drug, an ointment base and a solubilizing/dispersing agent
11/15/2012WO2012154627A2 Light delivery device and related compositions, methods and systems
11/15/2012WO2012153870A1 Therapeutic material for glaucoma
11/15/2012WO2012153125A1 Novel compounds and methods for use in medicine
11/15/2012WO2012152295A1 Pyrazolyl compounds for use in reversing reactive gliosis
11/15/2012WO2012100109A3 Therapeutic eye drop comprising doxycycline and a stabilizer
11/15/2012WO2012012184A3 Ophthalmic devices containing chemokine antagonists
11/15/2012US20120289679 Novel mite allergen
11/15/2012US20120289603 Enhanced bimatoprost ophthalmic solution
11/15/2012US20120289587 Compounds that modulate intracellular calcium
11/15/2012US20120289577 Composition for treating or preventing hearing loss comprising naphthoquinone-based compounds
11/15/2012US20120289552 Aryl ureas with angiogenesis inhibiting activity
11/15/2012US20120289542 Cicletanine in combination with oral antidiabetic and/or blood lipid-lowering agents as a combination therapy for diabetes and metabolic syndrome
11/15/2012US20120289541 Methods and compositions for applying moxifloxacin to the ear
11/15/2012US20120289526 Imidazolidinedione derivatives
11/15/2012US20120289518 Derivatives of 2-oxoalkyl-1-piperazin-2-one, preparation method thereof and therapeutic use of same
11/15/2012US20120289505 Inhibitors of diacylglycerol acyl transferase
11/15/2012US20120289501 Benzene-fused 6-membered oxygen-containing heterocyclic derivatives of bicyclic heteroaryls
11/15/2012US20120289484 Prodrugs of tetrahydrocannabinol, compositions comprising prodrugs of tetrahydrocannabinol and methods of using the same
11/15/2012US20120289463 Compositions and Methods for Promoting Epithelialization and Wound Closure
11/15/2012US20120288575 Cleanser compositions and methods for using the same
11/15/2012US20120288571 Antimicrobial Agents and Methods of Use
11/15/2012US20120288568 Methods and compositions for treating ophthalmic conditions via serum retinol, serum retinol binding protein (rbp), and/or serum retinol-rbp modulation
11/15/2012US20120288493 Method of inhibitng complement activation with human anti-factor c3 antibodies and use thereof
11/15/2012US20120288482 Therapeutic agent (y-39983) for corneal endothelial dysfunction
11/15/2012US20120288480 Cell population comprising orbital fat-derived stem cells (ofscs) and their isolation and applications
11/15/2012CA2835343A1 Stable povidone-iodine compositions with steroids or non-steroidal anti-inflammatories
11/14/2012EP2521547A2 Methods and compositions for applying moxifloxacin to the ear
11/14/2012CN1675250B Epimerized derivatives of K5 polysaccharide with a very high degree of sulfation
11/14/2012CN102781435A Combination of carotenoids and epi-lutein
11/14/2012CN102772768A Dampness and phlegm-eliminating and qi-regulating tablet
11/14/2012CN102772761A Tablets for removing heat to cool blood and soothing liver-qi stagnation
11/14/2012CN102772707A Chinese herbal preparation for treating eye diseases
11/14/2012CN102772698A Traditional Chinese medicine for relieving glaucoma early symptoms
11/14/2012CN102772687A Traditional Chinese medicine lotion for treating hot eyes and sore pain
11/14/2012CN102772572A Nutritive health product for protecting eyes and improving eyesight
11/14/2012CN102772537A Multifunctional special efficiency traditional Chinese medicine tincture for external use
11/14/2012CN102772504A Tuoli detoxicating tablet
11/14/2012CN102772479A Medical composite and preparation method, test method and application thereof
11/14/2012CN102772420A Swine bile phthalate eye drops and preparation method thereof
11/14/2012CN102772415A Anti-angiogenic agents and methods of use
11/14/2012CN102772393A Application of isobavachalcone in treating nerve inflammatory diseases
11/14/2012CN102772389A Water-soluble vitamin E soft capsule and preparation method thereof
11/14/2012CN102771861A Functional drink recipe for preventing three-high, fat and inner fire and manufacturing method of functional drink recipe for preventing three-high, fat and inner fire
11/14/2012CN102198193B Method for preparing Chinese medicine for treating wind- and fire-rooted glaucoma
11/14/2012CN102078619B Transdermal therapeutic preparation
11/14/2012CN102008437B Rapamycin microemulsion injection for eyes and preparation method and application thereof
11/14/2012CN101940553B Folic acid-vincristine targeted and slow-released nano-microspheres, prepared method and application thereof
11/14/2012CN101897671B Xylitol micro pill preparations and preparation method thereof
11/14/2012CN101815513B Ophthalmic formulation containing paracetamol
11/14/2012CN101626771B Therapeutic agent for meniere's disease
11/14/2012CN101619062B Natural fibrauretine crystal and macroporous adsorbent resin preparation method thereof
11/14/2012CN101309909B 2-phenylethylamino derivatives as calcium and/or sodium channel modulators
11/13/2012US8309609 Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands
11/13/2012US8309084 Chimeric and humanized antibodies to α5β1 integrin that modulate angiogenesis
11/08/2012WO2012078647A3 Chemical composition to detect and treat amyloid in a patient's brain and retina
11/08/2012US20120283309 Sirna compounds comprising terminal substitutions
11/08/2012US20120283295 Indazole derivatives and their use for blockading voltage dependent sodium channels
11/08/2012US20120283260 Bradykinin receptor agonists and uses thereof to treat ocular hypertension and glaucoma
11/08/2012US20120283258 Mediators of hedgehog signaling pathways, compositions and uses related hereto
11/08/2012US20120283252 Process for preparing pharmaceutical ophthalmic compositions
11/08/2012US20120283247 Diazepane acetamide derivatives as selective 11b-hsd1 inhibitors
11/08/2012US20120283243 Spiroindoline Modulators of Muscarinic Receptors
11/08/2012US20120283238 Irak inhibitors and uses thereof
11/08/2012US20120283231 Delivery Of Corticosteroids Through Iontophoresis
11/08/2012US20120283229 1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties
11/08/2012US20120283217 Modulators of amyloid-beta production
11/08/2012US20120283191 Approach To Treat Intraocular Hypertension
11/08/2012US20120283184 Inhibitors of type 2 vascular endothelial growth factor receptors
11/08/2012US20120283181 Crystal forms of saxagliptin and processes for preparing same
11/08/2012US20120283169 Pharmaceutical composition, methods for treating and uses thereof
11/08/2012US20120283168 Template-fixed peptidomimetics with ccr10 antagonistic activity
11/08/2012US20120282336 Bilayer tablet formulations
11/08/2012US20120282330 Chinese herbal composition for the treatment of macular degeneration and the process for manufacturing the same
11/08/2012US20120282326 Compositions and methods related to mirna in diabetic conditions
11/08/2012US20120282318 Sheet for corneal transplants
11/08/2012US20120282252 5Imidazoquinolines and Pyrimidine Derivatives as Potent Modulators of VEGF-Driven Angiogenic Processes
11/08/2012US20120282242 Compositions, targets, methods and devices for the therapy of ocular and periocular disorders
11/08/2012US20120282230 Methods and compositions for diagnosis and treatment of genetic and retinal disease
11/08/2012US20120282211 Antibodies and conjugates for modulators of angiogenesis
11/08/2012US20120282198 Cosmetic and/or pharmaceutical composition comprising an extract of carob as active agent for activating aquaporin expression
1 ... 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 ... 531